Valeant Pharmaceuticals

October 28, 2013

Valeant Pharmaceuticals (VRX) agreed to pay a $142.5 mil settlement to Anacor Pharmaceuticals. Anacor (ANAC) claims that Dow Pharmaceutical Services, now part of Valeant, broke a contract related to Anacor's work on a treatment for a fungal infection of the nail. Valeant shares fell 1.9% to 110.42. Anacor shares fell 3% to 12.47.